Please assess the completion status of the following clinical trial:

Trial Title: A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Written informed consent obtained by parents/legal representative (according to local regulation) prior to or after birth~2. Inborn neonates from 28+0 to 32+6 weeks of gestational age (GA), spontaneously breathing and stabilised on nCPAP~3. Clinical course consistent with RDS.~4. Receiving CPAP pressure 5-8 centimeter of water (cm H2O) and fraction of inspired oxygen (FiO2) between 0.25 and 0.40 to maintain saturation of peripheral oxygen (SpO2) between 88% and 95% for at least 30 minutes. Randomization should occur between 60 minutes and 12 hours after birth.~Exclusion Criteria:~1. Early need for endotracheal intubation for cardiopulmonary resuscitation in delivery room or within 1 hour from birth because of severe RDS~2. Respiratory Distress not secondary to surfactant deficiency~3. Use of surfactant prior to study entry and need for endotracheal administration of any other treatment.~4. Major congenital anomalies.~5. Evidence of severe birth asphyxia~6. Mothers with prolonged rupture of the membranes~7. Presence of air leaks.~8. Presence of IVH (intraventricular hemorrhage ) ≥ III.~9. Hypotension or evidence of hemodynamic instability.~10. Any condition that, in the opinion of the Investigator, would place the neonate at undue risk.~11. Participation in another clinical trial

- Gender: ALL
- Minimum Age: 28 Weeks
- Maximum Age: 32 Weeks
- Healthy Volunteers: f

Study Arms:
- nCPAP+ Nebulised Curosurf® (Type: EXPERIMENTAL): Curosurf® administered through nebulization
- nCPAP alone (control) (Type: OTHER): Standard of care, respiratory support used also during experimental arms

Based on this trial design, predict the completion outcome and termination type (if applicable).